Pathology Analysis & Statistics, February 2015

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publishers

  • All
    • Global Data

All regions

1-30 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023

  • $ 7 995
  • Industry report
  • November 2014
  • by Global Data

OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023 Summary There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment ...

  • Industries : Pathology
  • Countries : United States, World
PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - 5EU Drug ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, Europe, World
PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - China ...

  • Industries : Pathology
  • Countries : China
PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - Japan ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - US Drug ...

  • Industries : Pathology
  • Countries : United States
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China
EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023 Summary Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

  • Industries : Pathology
  • Countries : World, United States
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks ...

  • Industries : Pathology
  • Countries : Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Imprime PGG (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TS-1 (Colorectal Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : Japan
Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zaltrap (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, Europe, United States, United Kingdom
Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lonsurf (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avastin (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Nintedanib (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Vectibix (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “MGN1703 (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United Kingdom
Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cyramza (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stivarga (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Colorectal Cancer - Current and Future Players”. The report is a vital source ...

  • Industries : Pathology
  • Countries : World
Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014

Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014" provides data on the Iron Deficiency ...

  • Industries : Pathology
  • Countries : World
Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides ...

  • Industries : Pathology
  • Countries : World, United States
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Severe Acute Respiratory Syndrome (SARS) Coronavirus ...

  • Industries : Pathology
  • Countries : World
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Clostridium Difficile Infections (Clostridium ...

  • Industries : Pathology
  • Countries : World
Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2014" provides data ...

  • Industries : Pathology
  • Countries : World
Cystic Fibrosis Global Clinical Trials Review, H2, 2014

Cystic Fibrosis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Cystic Fibrosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2014" provides data on the Cystic Fibrosis clinical ...

  • Industries : Pathology
  • Countries : World, United States
Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Orion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung ...

  • Industries : Pathology
  • Countries : United States
Zoll Medical Corporation - Product Pipeline Analysis, 2014 Update

Zoll Medical Corporation - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary ZOLL Medical Corporation (Zoll) undertakes the designing, manufacturing and marketing of resuscitation devices and systems used for emergency resuscitation of cardiac arrest victims. It develops ...

  • Industries : Pathology
Vitatex Inc. - Product Pipeline Analysis, 2014 Update

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Vitatex Inc. (Vitatex) is a biotechnology company. The company research and develops new immunochemistry assays and reagents for the in-vitro diagnostic market. Its research products include Vita-Assays, ...

  • Industries : Pathology
  • Countries : United States
ProCelo AS - Product Pipeline Analysis, 2014 Update

ProCelo AS - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary ProCelo AS (ProCelo) is a medical device company. The company develops and markets diagnostic assays for detection of bacterial infections. Its ProCt product is a diagnostic kit which is used fo ...

  • Industries : Pathology
  • Countries : United States, Norway
About 34 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the UK

  • February 2015
    7 pages
  • Pathology  

    Obesity  

  • United Kingdom  

View report >

20 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Eli Lilly and Co.

United States

C.R. Bard Inc.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.